The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
Open accessAbstract
Objective: The prevalence of mitochondrial disease has proven difficult to establish, predominantly as a result of clinical and genetic heterogeneity. The phenotypic spectrum of mitochondrial disease has expanded significantly since the original reports that associated classic clinical syndromes with mitochondrial DNA (mtDNA) rearrangements and point mutations. The revolution in genetic technologies has allowed interrogation of the nuclear genome in a manner that has dramatically improved the diagnosis of mitochondrial disorders. We comprehensively assessed the prevalence of all forms of adult mitochondrial disease to include pathogenic mutations in both nuclear and mtDNA. Methods: Adults with suspected mitochondrial disease in the North East of England were referred to a single neurology center from 1990 to 2014. For the midyear period of 2011, we evaluated the minimum prevalence of symptomatic nuclear DNA mutations and symptomatic and asymptomatic mtDNA mutations causing mitochondrial diseases. Results: The minimum prevalence rate for mtDNA mutations was 1 in 5,000 (20 per 100,000), comparable with our previously published prevalence rates. In this population, nuclear mutations were responsible for clinically overt adult mitochondrial disease in 2.9 per 100,000 adults. Interpretation: Combined, our data confirm that the total prevalence of adult mitochondrial disease, including pathogenic mutations of both the mitochondrial and nuclear genomes (≈1 in 4,300), is among the commonest adult forms of inherited neurological disorders. These figures hold important implications for the evaluation of interventions, provision of evidence‐based health policies, and planning of future services. Ann Neurol 2015 Ann Neurol 2015;77:753–759
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
CONSORT statement: extension to cluster randomised trials
Campbell, M. K., Elbourne, D. R., & Altman, D. G. (2004) · BMJ · doi:10.1136/bmj.328.7441.702 · Cited by 2,557
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Shoffner, J. M., Lott, M. T., Lezza, A. M. S., Seibel, P., Ballinger, S. W., & Wallace, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90059-n · Cited by 1,482
Norwood, F. L. M., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., & Straub, V. (2009) · Brain · doi:10.1093/brain/awp236 · Cited by 541
Self-citationPrevalence of mitochondrial DNA disease in adults
Schaefer, A. M., McFarland, R., Blakely, E. L., He, L., Whittaker, R. G., Taylor, R. W., Chinnery, P. F., & Turnbull, D. M. (2008) · Annals of Neurology · doi:10.1002/ana.21217 · Cited by 494
Self-citationThe Epidemiology of Leber Hereditary Optic Neuropathy in the North East of England
Man, P. Y. W., Griffiths, P. G., Brown, D. T., Howell, N., Turnbull, D. M., & Chinnery, P. F. (2003) · The American Journal of Human Genetics · doi:10.1086/346066 · Cited by 483
Self-citationMolecular Diagnosis of Infantile Mitochondrial Disease with Targeted Next-Generation Sequencing
Calvo, S. E., Compton, A. G., Hershman, S. G., Lim, S. C., Lieber, D. S., Tucker, E. J., Laskowski, A., Garone, C., Liu, S., Jaffe, D. B., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003310 · Cited by 476
Majamaa, K., Moilanen, J. S., Uimonen, S., Remes, A. M., Salmela, P. I., Kärppä, M., Majamaa-Voltti, K. A. M., Rusanen, H., Sorri, M., Peuhkurinen, K. J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301959 · Cited by 386
Taylor, R. W., Pyle, A., Griffin, H., Blakely, E. L., Duff, J., He, L., Smertenko, T., Alston, C. L., Neeve, V. C., Best, A., et al. (2014) · JAMA · doi:10.1001/jama.2014.7184 · Cited by 366
Self-citationThe clinical maze of mitochondrial neurology
DiMauro, S., Schon, E. A., Carelli, V., & Hirano, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.126 · Cited by 353
A neurological perspective on mitochondrial disease
McFarland, R., Taylor, R. W., & Turnbull, D. M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70116-2 · Cited by 316
Self-citationRisk of developing a mitochondrial DNA deletion disorder
Chinnery, P. F., DiMauro, S., Shanske, S., Schon, E. A., Zeviani, M., Mariotti, C., Carrara, F., Lombes, A., Laforet, P., Ogier, H., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16851-7 · Cited by 232
Self-citationPfeffer, G., Gorman, G. S., Griffin, H., Kurzawa-Akanbi, M., Blakely, E. L., Wilson, I., Sitarz, K., Moore, D., Murphy, J. L., Alston, C. L., et al. (2014) · Brain · doi:10.1093/brain/awu060 · Cited by 175
Self-citationDisease progression in patients with single, large-scale mitochondrial DNA deletions
Grady, J. P., Campbell, G. R., Ratnaike, T. E., Blakely, E. L., Falkous, G., Nesbitt, V., Schaefer, A. M., McNally, R., Gorman, G. S., Taylor, R. W., et al. (2013) · Brain · doi:10.1093/brain/awt321 · Cited by 118
Self-citationURINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE m.3243A>G mtDNA MUTATION
Whittaker, R. G., Blackwood, J. K., Alston, C. L., Blakely, E. L., Elson, J. L., McFarland, R., Chinnery, P. F., Turnbull, D. M., & Taylor, R. W. (2009) · Neurology · doi:10.1212/01.wnl.0000342121.91336.4d · Cited by 100
Self-citationHao, H., Bonilla, E., Manfredi, G., DiMauro, S., & Moraes, C. T. (1995) · Europe PMC (PubMed Central) · Cited by 97
Blakely, E. L., Yarham, J. W., Alston, C. L., Craig, K., Poulton, J., Brierley, C. K., Park, S., Dean, A., Xuereb, J. H., Anderson, K. N., et al. (2013) · Human Mutation · doi:10.1002/humu.22358 · Cited by 78
Self-citationHanna, M. G., Nelson, I. P., Sweeney, M. G., Cooper, J. A. D., Watkins, P., MORGAN-HUGHES, J. A., & Harding, A. E. (1995) · Europe PMC (PubMed Central) · Cited by 74
Gorman, G. S., Pfeffer, G., Griffin, H. R., Blakely, E. L., Kurzawa‐Akanbi, M., Gabriel, J., Sitarz, K. S., Roberts, M., Schoser, B. G. H., Pyle, A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1753 · Cited by 45
Self-citation
Cited by
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.80 · Cited by 1,563
Self-citationThe dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease
Stewart, J. B., & Chinnery, P. F. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3966 · Cited by 1,031
Self-citationThe role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis
Zheng, L., Zhang, Z., Sheng, P., & Mobasheri, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101249 · Cited by 741
Mammalian Mitochondria and Aging: An Update
Kauppila, T. E. S., Kauppila, J. H. K., & Larsson, N.-G. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.017 · Cited by 578
Mitochondrial Diseases: Hope for the Future
Russell, O. M., Gorman, G. S., Lightowlers, R. N., & Turnbull, D. M. (2020) · Cell · doi:10.1016/j.cell.2020.02.051 · Cited by 459
Self-citation
Metadata
- Authors
- Gorman, G. S., Schaefer, A. M., Ng, Y., Gomez, N., Blakely, E. L., Alston, C. L., Feeney, C., Horvath, R., Yu‐Wai‐Man, P., Chinnery, P. F., Taylor, R. W., Turnbull, D. M., & McFarland, R.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2015-03-28
- Volume
- 77
- Issue
- 5
- Pages
- 753-759
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1521947818
- Cited by
- 936
- References
- 20
- FWCI
- 26.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.